Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment

NCT03230162 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT03230162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03230162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Unknown status
Start date
June 1, 2017
Completion date
May 1, 2018
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth abnormality, fetal growth restriction